At the sixth week postoperatively, we demonstrated that p-ERK1/2, p-p38 and p-JNK were significantly downregulated in the NAFLD+SG group compared with the NAFLD+SHAM and NAFLD+FR group (Figure 5B). The gene discussed is MAPK3; the disease is metabolic dysfunction-associated steatotic liver disease.